当前位置: 首页 > 详情页

Intractable diseases treated with intra-bone marrow-bone marrow transplantation

文献详情

资源类型:
机构: [a]Department of Stem Cell Disorders, Kansai Medical University, Hirakata City, Japan [b]Department of Cardiac Surgery, Beijing Institute of Heart, Lung and Blood Vessel Disease, Beijing Anzhen Hospital Affiliated to Capital Medical University, Beijing, China
出处:
ISSN:

关键词: Autoimmune diseases Intra-bone marrow-bone marrow transplantation Malignant tumors Mesenchymal stem cell Rheumatoid arthritis

摘要:
Bone marrow transplantation (BMT) is used to treat hematological disorders, autoimmune diseases (ADs) and lymphoid cancers. Intra bone marrow-BMT (IBM-BMT) has been proven to be a powerful strategy for allogeneic BMT due to the rapid hematopoietic recovery and the complete restoration of T cell functions. IBM-BMT not only replaces hematopoietic stem cells (HSCs) but also mesenchymal stromal cells (MSCs). MSCs are multi-potent stem cells that can be isolated from bone marrow (BM), umbilical cord blood (UCB), and adipose tissue. MSCs play an important role in the support of hematopoiesis, and modify and influence the innate and adaptive immune systems. MSCs also differentiate into mesodermal, endodermal and ectodermal lineage cells to repair tissues. This review aims to summarize the functions of BM-derived-MSCs, and the treatment of intractable diseases such as rheumatoid arthritis (RA) and malignant tumors with IBM-BMT. © 2014 Li, Guo and Ikehara.

语种:
PubmedID:
中科院(CAS)分区:
出版当年[2013]版:
最新[2023]版:
大类 | 2 区 生物学
小类 | 2 区 发育生物学 3 区 细胞生物学
第一作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院